Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.

about

Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.

Item

http://www.wikidata.org/entity/Q49166910

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Molecular and functional signa ...... ed by quantitative proteomics.

@en

Molecular and functional signa ...... ed by quantitative proteomics.

@nl

type

Item

label

Molecular and functional signa ...... ed by quantitative proteomics.

@en

Molecular and functional signa ...... ed by quantitative proteomics.

@nl

prefLabel

Molecular and functional signa ...... ed by quantitative proteomics.

@en

Molecular and functional signa ...... ed by quantitative proteomics.

@nl

P1476

Molecular and functional signa ...... ed by quantitative proteomics.

@en

P2093

Ahbin Kim

http://www.w3.org/2001/XMLSchema#string

Dohyun Han

http://www.w3.org/2001/XMLSchema#string

Dong Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Inhee Mook-Jung

http://www.w3.org/2001/XMLSchema#string

Jinhee Yang

http://www.w3.org/2001/XMLSchema#string

Jongmin Woo

http://www.w3.org/2001/XMLSchema#string

Joonho Park

http://www.w3.org/2001/XMLSchema#string

Youngsoo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

ProteomeXchange provides globally coordinated proteomics data submission and dissemination

P2888

s13024-017-0234-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13024-017-0234-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100433828

http://www.w3.org/2001/XMLSchema#string

P698

29338754

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5771139

http://www.w3.org/2001/XMLSchema#string